THE FIRST NATIONS HEALTH MANAGERS ASSOCIATION TO LEAD MULTI-YEAR INDIGENOUS HEALTH NAVIGATORS (IHN) TRAINING AND CURRICULUM DEVELOPMENT INITIATIVE
OTTAWA, ON, /CNW/ - The First Nations Health Managers Association (FNHMA) is leading a multi-year project focused on developing a comprehensive training and curriculum program for Indigenous Health Navigators (IHN).
IHNs have been recognized as essential roles within the Indigenous health system workforce. These professionals possess a deep understanding of the complex jurisdictional health landscape and the historical and current realities faced by First Nations patients and families. IHNs provide culturally safe and trauma-informed support, acting as vital bridges between community-based health services and the mainstream health systems often accessed in urban settings.
Through this initiative, FNHMA will support the development of a national network by identifying and establishing standardized competencies that reflect the diverse skill set of the current workforce. These competencies are intended to complement the work of First Nations Health Managers and strengthen the overall health management framework within First Nations communities.
Building on previous foundational work, the project will assess the existing landscape of the IHN role, propose a vision for its future evolution, and identify best practices and accredited training opportunities. Additionally, the initiative will focus on the development of core competencies, curriculum, and instructional materials, while delivering an actionable implementation plan to meet workforce needs and enhance career pathways for IHN.
This initiative reflects FNHMA's ongoing commitment to capacity building and the advancement of Indigenous-led health services. As always, FNHMA's approach is grounded in engagement with its' members and partners whose knowledge and lived experience is instrumental in guiding the project's direction.
FNHMA is pleased to announce that Dr. Pamela Toulouse has been appointed as the Lead Consultant for this initiative. Dr. Toulouse is a respected educator, researcher, and advocate with extensive experience in Indigenous health, education, and community empowerment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
6 hours ago
- Cision Canada
THE FIRST NATIONS HEALTH MANAGERS ASSOCIATION TO LEAD MULTI-YEAR INDIGENOUS HEALTH NAVIGATORS (IHN) TRAINING AND CURRICULUM DEVELOPMENT INITIATIVE
OTTAWA, ON, /CNW/ - The First Nations Health Managers Association (FNHMA) is leading a multi-year project focused on developing a comprehensive training and curriculum program for Indigenous Health Navigators (IHN). IHNs have been recognized as essential roles within the Indigenous health system workforce. These professionals possess a deep understanding of the complex jurisdictional health landscape and the historical and current realities faced by First Nations patients and families. IHNs provide culturally safe and trauma-informed support, acting as vital bridges between community-based health services and the mainstream health systems often accessed in urban settings. Through this initiative, FNHMA will support the development of a national network by identifying and establishing standardized competencies that reflect the diverse skill set of the current workforce. These competencies are intended to complement the work of First Nations Health Managers and strengthen the overall health management framework within First Nations communities. Building on previous foundational work, the project will assess the existing landscape of the IHN role, propose a vision for its future evolution, and identify best practices and accredited training opportunities. Additionally, the initiative will focus on the development of core competencies, curriculum, and instructional materials, while delivering an actionable implementation plan to meet workforce needs and enhance career pathways for IHN. This initiative reflects FNHMA's ongoing commitment to capacity building and the advancement of Indigenous-led health services. As always, FNHMA's approach is grounded in engagement with its' members and partners whose knowledge and lived experience is instrumental in guiding the project's direction. FNHMA is pleased to announce that Dr. Pamela Toulouse has been appointed as the Lead Consultant for this initiative. Dr. Toulouse is a respected educator, researcher, and advocate with extensive experience in Indigenous health, education, and community empowerment.
Cision Canada
14 hours ago
- Cision Canada
Approved by Health Canada - Zilia Ocular: A World First Set to Revolutionize Eye Care
QUEBEC CITY, June 19, 2025 /CNW/ - Zilia, a Canadian health technology company, is proud to announce that its flagship product, the Zilia Ocular™, has received approval from Health Canada. It is the first device in the world authorized to measure oxygen saturation in the eye—a breakthrough that has the potential to redefine eye care. Developed in Quebec City, the Zilia Ocular is a revolutionary retinal camera equipped with a patented optical technology that enables the non-invasive measurement of oxygenation in the eye. This metabolic biomarker gives eye care professionals an entirely new window into the physiological state of the eye, with the goal of detecting issues well before structural damage occurs. "This represents a true paradigm shift," said Dr. Patrick Sauvageau, optometrist, CEO and co-founder of Zilia. "By measuring retinal oxygenation in real time, we aim to help clinicians detect and manage eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration more effectively." A Breakthrough at the Heart of Oculomics As oculomics—an emerging field that uses the eye as a gateway to assess overall health—gains traction globally, biomarkers like oxygen saturation are paving the way for a more preventive, personalized, and data-driven approach to medicine. The Zilia Ocular is at the forefront of this movement, introducing a layer of analysis that was previously inaccessible in clinical settings. Zilia plans to launch its device in Canada in the coming months, followed by expansion into the United States and Europe. About Zilia Zilia is a health technology company developing a groundbreaking platform to non-invasively measure biomarkers in the eye, with an initial focus on ocular oximetry. By integrating advanced photonics and artificial intelligence, Zilia's first-of-kind technology is intended to leverage the eye's optical properties and direct connections to the vascular system and the brain to capture critical information on ocular and overall health.
Cision Canada
15 hours ago
- Cision Canada
Chronic Conditions Collide: The Rising Complexity of Long-Term Disability Claims Français
Sun Life data shows many Canadians on disability are living with more than one chronic health condition TORONTO, June 19, 2025 /CNW/ - The latest report in Sun Life's Designed for Health series reveals a troubling trend in long-term disability (LTD) claims among Canadians. Mental disorders, circulatory disorders and cancer are the top three reasons for LTD, but their claims don't stop there. Employees on disability leave are increasingly struggling with multiple, overlapping health disorders, making their LTD claim more complex. Multiple chronic conditions (known as "comorbidities" or "multiple morbidities") have become more common among Canadians. Sun Life looked at the drug claims data from over 1.5 million people on LTD and found: Diabetes, mental disorders and cardiovascular conditions are among the top drug claims to treat a secondary condition. Members on LTD are two times more likely to claim for a chronic disease drug related to a secondary condition than those not on LTD. They are three times more likely to claim for chronic disease drugs, treating two or more conditions in addition to their primary LTD claim. Diabetes is a common thread throughout many LTD claims and illustrates how chronic health conditions are overlapping: Plan members on LTD leave are almost three times more likely to have a diabetes drug claim than others. Drug claims for diabetes are up 30% from 2019 to 2023 across all claimants, not just LTD. "Long-term disability claims are often complex and our data tells us that Canadians, more than ever, are struggling when it comes to their health and well-being," says Marie-Chantal Côté, Senior Vice-President, Sun Life Health. "Dealing with multiple chronic conditions can be challenging and requires a holistic and comprehensive approach to recovery. As a trusted health partner to millions of Canadians and their families, our mission is to empower our members with personalized solutions, ensuring easier access to the care they need." Supporting Employees on LTD to Return to Work The presence of two or more health issues often worsens the primary condition and makes disease management more complicated. This can mean a long and difficult road to recovery. Those with comorbidities often see a delay in returning to work and remain on claim for longer than the average claim. "The road to recovery looks different for everyone. When helping an employee return to health, it's important we look at the full picture of their health, from comorbidities to personal stressors, to come up with a treatment plan that is right for them," says Côté. "We take an empathic approach to care that helps employees regain a sense of normalcy." Sun Life takes a holistic approach to supporting our plan members. Some of the innovative health solutions we offer include: Psychosocial Questionnaire – Sun Life's innovative new tool allows case managers to gain a deeper understanding of plan member health. The questionnaire helps identity case complexity and ensures members get the timely, additional support and treatments they need. Medical Confidence – Through our partnership with Kii Health, Medical Confidence is offered to our members to enhance disability claim support by offering timely access to specialist care, saving plan members an average of 317 wait days for specialist appointments. 1 Pharmacogenomic testing – Allows plan members to find the right drug treatment faster by potentially eliminating or reducing the trial-and-error process of finding the right medication. Read the 2025 Designed for Health Report to learn more about the trends in long-term disability claims in Canada. About Sun Life Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of March 31, 2025, Sun Life had total assets under management of $1.55 trillion. For more information, please visit Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF. Note to editors: All figures in Canadian dollars To contact Sun Life media relations, please email [email protected].
